Company Filing History:
1 out of 1,744 
1 out of 3,539 
1 out of 20 Years Active: 2015-2017
Title: Cyriaque Beley: Innovator in Gene Therapy
Introduction
Cyriaque Beley is a prominent inventor based in Fontenay le Fleury, France. He has made significant contributions to the field of gene therapy, particularly through his innovative patents. With a total of 2 patents, Beley's work focuses on advancing therapeutic methods for various diseases.
Latest Patents
Cyriaque Beley's latest patents include groundbreaking inventions that enhance gene delivery systems. One of his notable patents is for "Capsid-free AAV vectors, compositions, and methods for vector production and gene delivery." This invention involves an isolated linear nucleic acid molecule that comprises a first adeno-associated virus (AAV) inverted terminal repeat (ITR), a nucleotide sequence of interest, and a second AAV ITR. Importantly, this nucleic acid molecule is devoid of AAV capsid protein coding sequences, allowing it to be applied to a host repeatedly without eliciting an immune response. Additionally, he has developed "Modified U7 snRNAs for treatment of neuromuscular diseases." This invention improves the activity of engineered U7 snRNAs used in RNA-based therapeutics, particularly for conditions such as Duchenne muscular dystrophy and spinal muscular atrophy.
Career Highlights
Throughout his career, Cyriaque Beley has worked with esteemed organizations, including the National Institute of Health and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to contribute significantly to medical research and innovation.
Collaborations
Cyriaque Beley has collaborated with notable professionals in his field, including Luis Garcia and Thomas Voit. These collaborations have further enriched his research and development efforts.
Conclusion
Cyriaque Beley's contributions to gene therapy through his innovative patents demonstrate his commitment to advancing medical science. His work continues to pave the way for new therapeutic approaches to treat complex diseases.